ESMO 2025 Poster Presentation: Ficerafusp alfa-driven tumor penetration via EMT and FMT inhibition in the tumor microenviornment

Bicara Therapeutics Inc. published this content on November 05, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 05, 2025 at 14:43 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]